What's new in Interventional Cardiology

At 10 years, the second-generation SAPIEN XT was associated with lower survival and higher reintervention than surgery in the randomised PARTNER 2A trial, whereas the third-generation SAPIEN 3 matched surgery in a propensity-matched registry comparison. Two analyses, one lesson: long-term outcome is defined by the valve...

Coronary microvascular dysfunction is increasingly recognised as a key determinant of outcomes beyond epicardial coronary disease. The FLOW-CMD registry provides new insights into its prevalence and prognostic impact in routine invasive practice.

In a secondary analysis of the randomised ORBITA-2 trial, focal coronary artery disease pattern as assessed by non-hyperaemic pressure wire pullback was associated with greater angina relief following PCI than diffuse pattern of disease.

At EuroPCR 2026, two awards highlighted innovation and emerging talent in interventional cardiology. Lene Andreasen received the Michele Pighi Young Investigator Award for her research on coronary bifurcation PCI from the OCTOBER trial, while Susheel Kodali and the Nyra Medical team were honoured with the Jon...

This one-of-a-kind academy offers independent, cutting-edge training pathways for ambitious interventionalists who have been in practice for a few years and are looking to grow - both personally and professionally. Two recurrent high-level one-year tracks on coronary interventions and TAVI are already underway, with further opportunities forecast for...

The Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to individuals who have contributed in an extraordinary way to the PCR mission.

PCR has developed an independent educational framework to facilitate the worldwide training of the next generation of interventional cardiologists in host centres that are renowned for their expertise. This new initiative supports practitioners at all stages of their career – promoting professional growth, geographical mobility and cultural exchange.

ViTAL® (Visionary Transformative Adult Learning) was born from a simple but demanding conviction: experienced professionals continue to learn best through interaction, reflection, shared experience, and active participation.

A 69-year-old woman with severe symptomatic aortic stenosis (NYHA III) and complex comorbidities, including three-vessel coronary artery disease, advanced COPD, and peripheral artery disease, presents with progressive dyspnoea despite recent PCI. How would you treat this patient?

Eugene Braunwald, whose work reshaped cardiovascular medicine into the rigorous, evidence-based discipline we know today, leaves behind an extraordinary scientific legacy. He transformed how we think about the heart: not just as an organ to observe, but as a system to understand, measure, and treat through...